Cardiac Devices

The cardiac device measures shear waves to derive active stress, addressing the lack of direct cardiac parameter access in non-invasive methods, enabling precise intraventricular pressure and lesion detection.

JP7579326B2Active Publication Date: 2024-11-07INRIA INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET EN AUTOMATIQUE +1
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2022506681
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-08-01
Filing Date
2020-07-29
Publication Date
2024-11-07
Estimated Expiration
2040-07-29

AI Technical Summary

Technical Problem

Current non-invasive cardiac measurement methods lack direct access to useful cardiac parameters, such as central blood pressure and cardiac lesions, due to imprecise relationships between radial artery blood pressure and heart parameters, and existing techniques like cardiac elastography provide estimated stiffness without a clear correlation.

Method used

A cardiac device comprising a transmitter, probe, detector, and estimator to measure shear waves and derive active stress from cardiac systole, allowing direct non-invasive access to cardiac parameters like intraventricular pressure and detection of cardiac lesions.

Benefits of technology

Enables direct and non-invasive measurement of active stress in heart tissue, providing accurate intraventricular pressure and enabling detection of cardiac lesions, such as myocardial infarction sequelae, with high precision and reliability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007579326000002
    Figure 0007579326000002
  • Figure 0007579326000003
    Figure 0007579326000003
  • Figure 0007579326000004
    Figure 0007579326000004
Patent Text Reader

Abstract

The cardiac device comprises a transmitter (10) arranged to transmit at least one wave, a probe (12) arranged to measure shear waves caused by the waves from the transmitter (10), a detector (14) arranged to detect systole in an electrocardiogram signal, and an estimator (16) arranged to determine, during at least one cardiac cycle, the propagation velocities of multiple shear waves caused by the waves being transmitted in multiple directions towards the patient's heart, determine the maximum propagation velocity during systole using the detector (14), and derive an activation stress (160) of the heart from the result.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to the field of cardiac measurements, and more particularly to the field of non-invasive cardiac measurements.Cardiac measurements encompass the measurement of physical parameters, including in particular mechanical parameters, taken on a patient's heart. [Background technology]

[0002] Recent advances in imaging techniques, particularly ultrasound and magnetic resonance imaging, have allowed access to parameters that could only be measured by in situ methods, which require access to the heart by surgery or catheterization, making these methods invasive and restrictive, and only available in suitable facilities that are subject to strict regulations.

[0003] Non-invasive measurements, on the other hand, can be performed more easily. However, these measurements do not measure all useful or easily available parameters. For example, known methods for obtaining measurements of radial artery blood pressure use sensors placed close to the patient's skin, for example via a wristband, finger sensor or smartwatch. However, the association between radial artery blood pressure and physical parameters in the heart, such as central blood pressure, is imprecise and indirect.

[0004] Another known measurement method is cardiac elastography, either by magnetic resonance or ultrasound. This technique is non-invasive and is used to measure the estimated stiffness of cardiac tissue. The estimated stiffness is a parameter that varies during the heartbeat and depends on the site where it is measured. This estimated stiffness can theoretically be related to other useful cardiac parameters such as elastic modulus, cardiac pressure and tissue stress. However, there is no direct relationship between this measurement and these cardiac parameters. A correlation has already been observed between the estimated stiffness and cardiac pressure, but this varies greatly between individuals. Summary of the Invention [Problem to be solved by the invention]

[0005] Thus, there are no known methods for non-invasively accessing useful cardiac parameters. [Means for solving the problem]

[0006] The present invention aims to improve this situation. For this purpose, the invention provides a cardiac device comprising a transmitter arranged to transmit at least one wave, a probe arranged to measure shear waves caused by the waves from the transmitter, a detector arranged to detect systole in an electrocardiogram signal, and an estimator arranged to determine, during at least one cardiac cycle, the propagation velocities of a number of shear waves caused by the transmission of waves in a number of directions towards the patient's heart, to determine, during systole, the maximum propagation velocity using the detector, and to derive from the result an activation stress of the heart.

[0007] The device has the advantage that it provides direct access to the activity stress in cardiac tissue, meaning the force per unit area. This activity stress allows direct and non-invasive access to many useful cardiac parameters. For example, the intraventricular pressure can be derived from the activity stress. Furthermore, cardiac pathologies can be detected from the measurement of the activity stress. This allows, for example, the aftereffects of a myocardial infarction to be monitored.

[0008] In various alternative embodiments, the device may have one or more of the following features. The cardiac device comprises a calculator arranged to determine an intraventricular pressure from the ventricular wall thickness, the ventricular cavity radius and the activation stress determined by the estimator. The cardiac device includes an image analyzer arranged to determine a ventricular wall thickness and a ventricular cavity radius based on at least one image of the heart. At least one image of the heart is derived from shear wave imaging. The cardiac device further comprises an imager positioned to provide a shear wave image from the at least one shear wave measured by the probe. At least one wave from the transmitter is a compressional ultrasonic wave. The transmitter and probe are implemented in a two-dimensional echo probe having a probe orientation defining a propagation direction about which the probe can be rotated, and the estimator is arranged to determine a maximum propagation velocity based on measurements for three coplanar and non-colinear directions performed by the probe. The transmitter and the probe are mounted in a 3D ultrasound probe. - 3D ultrasound probes are 3D echo probes. [Brief description of the drawings]

[0009] Further features and advantages of the present invention will become more apparent from the following detailed description, which proceeds with reference to the accompanying drawings. [Figure 1] 1 is a schematic diagram of a cardiac device according to the present invention; [Diagram 2] 2 is a schematic diagram of the cardiac device shown in FIG. 1 in a position to measure intraventricular pressure. FIG. [Diagram 3] 3 is a schematic diagram of an alternative configuration of the cardiac device shown in FIG. 2. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] The accompanying drawings essentially contain elements of a specific nature of the present invention, and therefore they can not only serve to better understand the present invention, but also contribute accordingly to its definition.

[0011] Following this description is Appendix A, which contains mathematical formulas, which constitutes an integral part of this specification.

[0012] Please refer now to FIG.

[0013] The cardiac device 1 according to the invention comprises a memory 2 , a transmitter 10 and a probe 12 .

[0014] Memory 2 can be any type of data storage suitable for receiving digital data, such as a hard drive, a solid state drive (SSD), any form of flash drive, random access memory, a magnetic drive, cloud storage or local distributed storage. The data stored in memory 2 can be erased or saved after cardiac device 1 has performed its task. Data calculated by the cardiac device can be stored in memory 2 or any type of memory similar thereto.

[0015] Techniques have been developed for non-invasive monitoring of anisotropic (e.g. fibrous) media using ultrasound. For example, patent application PCT / FR2015 / 050058 relates to the measurement of mechanical properties in anisotropic media by monitoring the propagation of ultrasound.

[0016] The transmitter 10 in this case is a device capable of transmitting ultrasound waves. In response to the ultrasound waves transmitted by the transmitter 10 towards the fibrous tissue 4, for example the wall of the heart 6, which enter the fibrous tissue, shear waves propagate in the fibrous tissue in a plane perpendicular to the direction of transmission of the ultrasound waves. This propagation is observed by the probe 12 via high-speed transmitted compressed ultrasound waves, as described in patent application PCT / FR2015 / 050058.

[0017] The cardiac device 1 further comprises a detector 14 and an estimator 16. The detector 14 determines the instants when the observed heart is in systole, i.e. when the heart is contracting. The estimator 16 is connected to the transmitter 10, the probe 12 and the detector 14 so as to receive data from them. The estimator 16 is able to derive from these data one or more physical parameters, in particular the activity stress 160 in the cardiac tissue.

[0018] To perform propagation measurements, the transmitter 10 and probe 12 are placed in contact with the skin of the patient whose heart 6 is to be observed and are aimed towards the heart. The transmitter 10 and probe 12 work together to observe the propagation of shear waves in the cardiac tissue.

[0019] Transmitter 10 generates a short duration focused ultrasound beam in a transmit direction towards the heart 6. Upon reaching the heart, the beam is subjected to acoustic radiation pressure and induces a displacement in the cardiac tissue 4. This displacement is in the form of a shear wave that propagates within the cardiac tissue 4 in a propagation direction substantially perpendicular to the transmit direction.

[0020] The probe 12 monitors the propagation of shear waves. To this end, the probe 12 transmits ultrasonic waves in the form of compression waves at high speed towards the heart 6. The ultrasonic waves are reflected by the cardiac tissue 4, which is deformed under the influence of the shear waves. The reflected waves are detected by the probe 12, and thus the displacement of the cardiac tissue 4 can be observed. The probe 12 transmits ultrasonic waves at a speed of more than 300 Hz, or even more than 500 Hz. The propagation measurements of individual shear waves can be performed in a matter of a few milliseconds. The probe 12 can thus monitor the propagation of shear waves in the cardiac tissue 4 with high accuracy several hundred times per second. The probe 12 also determines the propagation speed of the shear waves. Furthermore, the probe 12 can correlate the determined propagation speed of the shear waves with their propagation direction.

[0021] The transmitter 10 and the probe 12 may be controlled by a user and / or a controller to operate together. In the embodiment described herein, the transmitter 10 and the probe 12 are connected to each other so as to communicate with each other.

[0022] Applicants have observed that the propagation velocity of shear waves in fibrous cardiac tissue is greatest when the waves propagate tangentially to the direction of the tissue fibers, and therefore by measuring multiple propagation velocities at different propagation directions, the orientation of the fibers in the fibrous tissue and the propagation velocity of the shear waves along these fibers can be determined.

[0023] More specifically, the problem of determining the propagation of shear waves along a fiber can be summarized in the form of Equation (1) in Appendix A, also known as the Christoffel equation, where the first term is also known as the Christoffel matrix M, where r is the density of cardiac tissue, F is the wave polarization vector, and V is the propagation speed of the plane wave.

[0024] In the course of his research, the applicant discovered that during systole, the active tension terms dominate in the stress tensor of the fibrous myocardial medium. This allowed him to reformulate the Christoffel matrix M of equation (1) in Appendix A into the general form of equation (2), where n1 is the cosine of the angle between the direction of wave propagation and the fiber direction, s 1D represents the activation stress. In this equation, the matrix M is expressed in a reference frame in which the first vector is the fiber direction. 1D *n1 2 (the second and third terms on the diagonal of matrix M) and feeding it back into equation (1) in Appendix A, we derived equation (3) in Appendix A. Applicant then established a relationship between maximum propagation velocity, cardiac tissue density and activation stress in the form of equation (4) in Appendix A, which corresponds to the case where n1 is equal to 1.

[0025] In this case, the density r is effectively 1,060 kg / m 3 Due to the high proportion of water in cardiac tissue, density r has low inter-individual variability. As a result, Applicant's invention can be used to measure activity stress in humans.

[0026] To determine the activation stress 160, it is first necessary to identify the systole. For this purpose, the detector 14 determines the systole on the basis of an electrocardiogram signal 140. The electrocardiogram signal 140 in this case is transmitted from an electrocardiograph 142 integrated in the cardiac device 1. Alternatively, the electrocardiogram signal 140 can originate from an external device of the cardiac device 1 and be stored in the memory 2. This alternative embodiment is not shown in the figures.

[0027] A systole lasts between 200 ms and 400 ms. Considering that the measurements performed by transmitter 10 and probe 12 are on the order of a few milliseconds in duration, multiple propagation velocity measurements can be performed during a single systole.

[0028] The estimator 16 in this case is a program executed by a processor of a computer. Alternatively, it can be realized in another way by a dedicated processor. The term "processor" means any processor adapted for the data processing operations described herein. Such a processor can be made in a known manner as a microprocessor for a personal computer, a dedicated chip of the FPGA or SoC (System-on-Chip) type, a computing resource on a grid, a microcontroller, or in any other form suitable for providing the necessary computing power to carry out the operations described below. One or more of these elements can also be made in the form of specialized electronic circuits, such as ASICs. A combination of electronic circuits and processors can also be considered.

[0029] The estimator 16 receives a set of propagation velocities determined by the probe 12. Each of the propagation velocities is associated with a propagation direction of that shear wave. The estimator 16 receives information indicative of systole from the detector 14. The estimator 16 determines a maximum propagation velocity of the shear wave during systole based on the set of propagation velocities.

[0030] To that end, the user or an external controller controls the transmission direction of the waves transmitted by the transmitter 10 so as to perform multiple propagation velocity measurements, on the basis of which the estimator 16 determines the maximum propagation velocity of the shear waves in the cardiac tissue 4, i.e. the fiber direction of the cardiac tissue 4.

[0031] For this purpose, the estimator 16 can perform multiple propagation velocity measurements in multiple propagation directions distributed in a plane tangent to the heart wall and extract the largest of the measured propagation velocities. The multiple propagation directions can be selected, for example, such that their angular distribution is substantially uniform. Furthermore, the estimator 16 can use equation (3) to interpolate a sinusoidal wave from at least three propagation velocity measurements derived from coplanar and non-colinear propagation directions of the waves transmitted by the transmitter 10 to derive the maximum propagation velocity of the shear wave in the cardiac tissue 4.

[0032] After determining the maximum propagation speed, the estimator 16 derives the activation stress 160 according to equation (4) in Appendix A.

[0033] In a first embodiment of the invention, the transmitter 10 and the probe 12 are implemented in a two-dimensional echo probe. Ultrasound waves are transmitted by the transmitter 10 and focused on the cardiac tissue. The probe 12 transmits very fast unfocused waves to image the shear wave propagation in a plane. By substantially rotating this plane around the probe's main axis, the ultrasound scans a cone or a part of a cone centered on this probe's main axis. This allows the user to manually rotate the two-dimensional echo probe to obtain multiple measurements of the propagation velocity in at least three propagation directions. The measurements of the propagation directions can be performed manually, automatically or guided. Thus, in a few seconds and through simple handling operations, the maximum propagation velocity of the shear wave can be determined as described above. It is very advantageous that the transmitter 10 and the probe 12 can be used in a two-dimensional echo probe, since the probe is inexpensive and available in most medical facilities. More generally, in this embodiment, the entire cardiac device 1 can be implemented in a conventional two-dimensional echo device.

[0034] In a second embodiment, the transmitter 10 and the probe 12 are implemented in a 3D echo probe. In this configuration, the transmitter 10 transmits ultrasound waves in multiple propagation directions, scanning a non-zero solid angle, for example a cone centered on the probe main axis. In this case, the measurement of the maximum propagation velocity can be obtained without moving or rotating the 3D echo probe. This allows the determination of the activation stress to be made more reliably, faster and more accurately. Furthermore, the cardiac device 1 in this case has the advantage that it can be implemented in a conventional 3D echo device.

[0035] In a third embodiment, the cardiac device 1 is implemented in a stand-alone instrument of the type described in patent application PCT / FR2015 / 050058, different from an echo instrument. This special instrument can be provided with a simpler design and at a lower cost, while achieving propagation measurements almost equivalent to those of a 3D echo probe. The transmitter 10 and the probe 12 are arranged to perform a measurement of the maximum propagation velocity without moving or rotating the stand-alone instrument. The part of the stand-alone instrument including the transmitter 10 and the probe 12 can have a size smaller than the intercostal distance. The small size can increase the accuracy of the measurements performed by the probe 12. The implementation of the cardiac device 1 in a stand-alone instrument of this type can simplify its manufacture. Moreover, in this configuration, the cardiac device 1 can be interfaced with a separate conventional medical instrument, to which it can transmit data, such as the specifically determined activation stress 160.

[0036] Next, please refer to FIG.

[0037] The applicant has discovered a method for determining the intraventricular pressure from the activity stress of the heart. To this end, the applicant has modeled the mechanical behavior in static equilibrium of a substantially spherical ventricular cavity with thickness d and radius R. Under pressure p, where e=d / R, the applicant has derived equation (5) in Appendix A, which relates the activity stress 160, thickness d, and radius R to the internal pressure 220, where a cor represents the correction factor. The thickness d and the radius R are the geometric data of the ventricular cavity.

[0038] In the embodiment described herein, the cardiac device 1 comprises a calculator 22. The calculator 22 receives the activation stress 160 from the estimator 16 and the geometric data 202. The calculator 22 determines the intraventricular pressure based on the activation stress 160 and the geometric data 202 using equation (5) in Appendix A.

[0039] Optionally, the cardiac device 1 may comprise an image analyzer 20 for generating geometric data 202 .

[0040] The image analyzer 20 acquires image data 200 from a ventricular cavity of the observed heart. The image analyzer 20 derives therefrom geometric data 202 of the ventricular cavity. The image analyzer 20 determines at least a ventricular wall thickness d and a ventricular cavity radius R of the ventricular cavity.

[0041] The image data 200 may be provided from cardiac imaging using ultrasound (echo), magnetic resonance imaging (MRI), computed tomography (CT), radiology (nuclear medicine) or any other non-invasive cardiac imaging technique. The image data may be stored in memory 2. In the embodiment described herein, the image data 200 is provided from a third party device.

[0042] The geometric data 202 (and image data 200 , if appropriate) are stored in a memory 2 .

[0043] In the first (and second) embodiment, the image analyzer 20 is connected to a 2D (and 3D) echo probe, which provides the image analyzer 20 with the necessary image data. And in the third embodiment, the cardiac device 1 provides the image analyzer 20 with the necessary image data. The image analyzer 20 can analyze the image data using machine learning methods or via algorithms. The image analyzer 20 can comprise, for example, a neural network, in particular a convolutional neural network, so as to be able to recognize shapes in the image data and derive geometrical data.

[0044] Echocardiograms of the heart can be used to determine the contours of the inner (endocardial) and outer (epicardial) walls of the heart, allowing measurements of the ventricular wall thickness d and the ventricular cavity radius R. Segmentation in this case can be manual or automatic.

[0045] Alternatively, a time / motion (TM) echo probe can provide an image representing the echo lines as a function of time, providing a visualized cardiac wall that can be manually or automatically segmented to calculate the ventricular wall thickness d and ventricular cavity radius R.

[0046] Approximating the ventricular cavity to a spherical shape, equation (5) is corThis correction factor can be determined in advance, for example by digital simulation, or can be measured for a group of patients. Alternatively, this correction factor can be determined in situ by components of the cardiac device 1 capable of geometric analysis or image analysis. This analysis can be performed, for example, by the image analyzer 20 from the image data 200. In the embodiment described here, the correction factor can be varied in the range of 0.6 to 1, preferably in the range of 0.75 to 0.95, and more preferably set to 0.9. The applicant has estimated the inter-individual variability of the correction factor to be about 10%. This variability is much smaller than the variability of known non-invasive pressure measurements. Thus, the calculator 22 and the image analyzer 20 can provide a non-invasive measurement of the intraventricular pressure 220 that is significantly more accurate than conventional methods.

[0047] Non-invasive measurement of the intraventricular pressure p by the cardiac device 1 allows for the diagnosis of several medical conditions through simple medical procedures using inexpensive equipment. For example, heart failure can be detected by measuring the intraventricular pressure using the cardiac device 1 implemented in a 2D echo probe. This non-invasive pressure measurement can also be used for cardiac resynchronization therapy.

[0048] The image analyzer 20 and the calculator 22 are programs executed by one or more processors of a computer, or may alternatively be implemented using a dedicated processor or on a separate machine.

[0049] Next, please refer to FIG.

[0050] In this embodiment, the cardiac device 1 includes an imager 24 for generating image data. When the cardiac device 1 is installed in an echo device, the imager 24 includes a portion of the echo device that performs one or more echo examinations.

[0051] The use of activation stress to measure intraventricular pressure has been described. The aftereffects of myocardial infarction can be observed from the contractility, i.e. the maximum value of activation stress. This contractility measurement can be carried out over the entire contraction cycle. Areas where the contractility is lower than normal are indicative of areas affected by myocardial infarction. [Appendix A]

[0052]

number

Claims

1. 1. A cardiac device comprising: a transmitter (10) arranged to transmit at least one wave, a probe (12) arranged to measure shear waves caused by the waves from the transmitter (10), a detector (14) arranged to detect systole in an electrocardiogram signal, and an estimator (16) arranged to determine, during at least one cardiac cycle, a propagation velocity of a plurality of said shear waves caused by the transmission of said waves in a plurality of directions towards the patient's heart, to determine, during systole, the one in which said propagation velocity is maximum using the detector (14), and to derive therefrom an activation stress (160) of the heart. Cardiac devices.

2. a calculator (22) arranged to determine an intraventricular pressure (220) from the ventricular wall thickness determined by said estimator (16), the ventricular cavity radius and said activation stress (160).

10. The cardiac device of claim 1.

3. an image analyzer (20) arranged to determine the ventricular wall thickness and the ventricular cavity radius based on at least one image of the heart.

3. The cardiac device of claim 2.

4. the image analyzer (20) is arranged to determine the ventricular wall thickness and the ventricular chamber radius based on at least one image of the heart derived from the shear wave imaging.

4. The cardiac device of claim 3.

5. and an imager (24) positioned to provide a shear wave image from at least one of the shear waves measured by the probe (12).

5. The cardiac device of claim 4.

6. The at least one wave from the transmitter (10) is a compressional ultrasonic wave. A cardiac device according to any one of claims 1 to 5.

7. the transmitter (10) and the probe (12) are implemented in a two-dimensional echo probe having a probe direction defining a propagation direction about which the probe can rotate, and the estimator (16) is arranged to determine a maximum propagation velocity based on measurements for three coplanar and non-colinear directions performed by the probe (12). A cardiac device according to any one of claims 1 to 6.

8. The transmitter (10) and the probe (12) are mounted on a three-dimensional ultrasound probe. A cardiac device according to any one of claims 1 to 6.

9. The three-dimensional ultrasound probe is a three-dimensional echo probe.

9. The cardiac device of claim 8.

Citation Information

Patent Citations

  • Ultrasonic diagnostic apparatus

    JP1998005226A

  • Multi-scan plane ultrasound imaging of the object

    JP2005520592A

  • Method and apparatus for measuring cardiac contractility

    JP2012528614A

  • Methods and ultrasonic devices for characterizing anisotropic flexible media, and sets of ultrasonic probes for such characterization devices

    JP2017504435A

  • How to obtain muscle function parameters

    JP2017520349A